EBITDA at other companies
Other financials
Where this comes from
Calculated from TriSalus Life Sciences, Inc.’s reported figures.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s EBITDA?
- TriSalus Life Sciences, Inc. (TLSI) reported EBITDA of -$8.28M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s EBITDA changed year-over-year?
- TriSalus Life Sciences, Inc.'s EBITDA decreased by 15.6% year-over-year, from -$7.16M to -$8.28M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s EBITDA?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s EBITDA has grown at a 8.8% compound annual growth rate (CAGR), from -$20.44M to -$26.32M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.